ACP5
ACP5 (acid phosphatase 5, tartrate resistant) is a binuclear iron-containing acid phosphatase that hydrolyses phosphate esters under acidic conditions. It is also known as TRAP, TRAcP and HPAP, and has roles in bone remodelling and immune regulation. Browse Assay Genie's current range of ACP5 research reagents below, or read on for the biology behind the target.
ACP5 functions as a binuclear Fe(III)-Fe(II) acid phosphatase that hydrolyses phosphate esters to alcohols and phosphate under acidic conditions. It dephosphorylates a broad range of substrates, including ADP and ATP, larger phosphoproteins such as osteopontin (SPP1) and bone sialoprotein (IBSP), and synthetic compounds such as para-nitrophenyl phosphate (p-NPP). Through dephosphorylation of bone matrix proteins, it contributes to normal cartilage mineralisation during skeletal development and to maintaining and remodelling bone integrity in adults. It promotes osteoclast migration by dephosphorylating SPP1, which binds osteoclasts to the bone matrix.
The ACP5 gene encodes an iron-containing glycoprotein that catalyses the conversion of orthophosphoric monoester to alcohol and orthophosphate. It is the most basic of the acid phosphatases and the only form not inhibited by L(+)-tartrate, which gives rise to the name tartrate-resistant acid phosphatase and the common abbreviations TRAP and TRAcP. The protein is found in the lysosome and is also secreted, and belongs to the purple acid phosphatase family within the metallophosphoesterase superfamily.
Beyond bone, ACP5 is involved in immune regulation and macrophage function, contributing to the breakdown of internalised pathogens within lysosomes. It regulates immune cell recruitment during infection, partly through interaction with SPP1. The uncleaved form, isoform 5a, functions primarily in immune regulation rather than bone resorption. ACP5 may also help remove mannose-6-phosphate from lysosomal proteins after their delivery to lysosomes, acting in concert with ACP2.
ACP5 dephosphorylates bone matrix proteins such as SPP1 and IBSP, supporting bone remodelling and integrity in adults.
ACP5 promotes osteoclast migration by dephosphorylating SPP1, which binds osteoclasts to the bone matrix.
ACP5 plays a role in normal cartilage mineralisation during skeletal development.
ACP5 contributes to macrophage function, lysosomal breakdown of pathogens and regulation of immune cell recruitment during infection.
ACP5 is a binuclear Fe(III)-Fe(II) acid phosphatase that hydrolyses phosphate esters under acidic conditions. It dephosphorylates ADP, ATP and phosphoproteins such as SPP1 and IBSP, supporting bone remodelling and osteoclast migration, and it also contributes to immune regulation and macrophage function.
ACP5 is the most basic of the acid phosphatases and the only form not inhibited by L(+)-tartrate. This property gives the enzyme its name and the aliases TRAP and TRAcP. HPAP is also listed as an alias. Isoform 5a is the uncleaved form, acting mainly in immune regulation.
Orthologues of the human ACP5 gene exist in mouse and rat, both named Acp5. Human ACP5 belongs to the purple acid phosphatase family of the metallophosphoesterase superfamily. Check the datasheet of any product for its validated reactivity.
Other acid phosphatases, including ACP2, which acts alongside ACP5 in lysosomes.
Gene and protein annotations from HGNC, NCBI Gene and UniProt P13686; product specifications from Assay Genie datasheets.